APA aipamena

Kammüller, M., Tsai, T., Griffiths, C. E., Kapoor, N., Kolattukudy, P. E., Brees, D., . . . Fox, T. (2017). Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections. Clin Transl Immunology.

Chicago Style aipamena

Kammüller, Michael, Tsen-Fang Tsai, Christopher EM Griffiths, Nidhi Kapoor, Pappachan E. Kolattukudy, Dominique Brees, Salah-Dine Chibout, Jorge Safi Jr, and Todd Fox. "Inhibition of IL-17A By Secukinumab Shows No Evidence of Increased Mycobacterium Tuberculosis Infections." Clin Transl Immunology 2017.

MLA aipamena

Kammüller, Michael, et al. "Inhibition of IL-17A By Secukinumab Shows No Evidence of Increased Mycobacterium Tuberculosis Infections." Clin Transl Immunology 2017.